Key result
Total thyroidectomy safely and rapidly corrected refractory amiodarone-induced thyrotoxicosis in a 48-year-old patient with severe cardiac disease, enabling resumption of amiodarone therapy.
Why the study?
Does total thyroidectomy safely correct refractory amiodarone-induced thyrotoxicosis in patients with severe cardiac disease?
Case Report (n=1)
Does total thyroidectomy safely correct refractory amiodarone-induced thyrotoxicosis in patients with severe cardiac disease?
Total thyroidectomy can be performed safely and should be considered early for patients with severe cardiac disease and refractory amiodarone-induced thyrotoxicosis.
May support early thyroidectomy in refractory amiodarone-induced thyrotoxicosis with severe cardiac disease; hypothesis-generating and requires prospective confirmation.
Amiodarone-induced thyrotoxicosis is often poorly tolerated owing to underlying cardiac disease, and frequently resistant to medical therapy. We describe a 48-year-old patient with severe cardiac disease who developed amiodarone-associated thyrotoxicosis, refractory to standard medical therapy. Due to the unremitting thyrotoxicosis, a total thyroidectomy was performed without complications resulting in rapid correction of the thyrotoxicosis and enabling resumption of amiodarone therapy. Despite the concerns inherent to severe cardiac disease, total thyroidectomy can be performed safely in patients with resistant amiodarone-induced thyrotoxicosis. We believe that surgery should be considered early in the treatment planning. How to cite this article Ishay A, Carmeli J, Rozner E, Luboshitzky R. Refractory Amiodarone-induced Thyrotoxicosis: The Surgical Option. World J Endoc Surg 2013;5(1):21-24.
No takes yet. Share an insight, caveat, or question.
Ishay et al. (2013) conducted a case report in Amiodarone-induced thyrotoxicosis (n=1). Total thyroidectomy was evaluated on Correction of thyrotoxicosis and resumption of amiodarone therapy. Total thyroidectomy safely and rapidly corrected refractory amiodarone-induced thyrotoxicosis in a 48-year-old patient with severe cardiac disease, enabling resumption of amiodarone therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: